Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I clinical study of intratumoral injection of oncolytic Clostridium novyi-NT spores in patients with advanced cancers
    Meeting Abstract

    Janku, F.; Murthy, R.; Wang-Gillam, A.; Shepard, D.; Helgason, T.; Henry, T.; Rudin, C.; Huang, S.; Sakamuri, D.; Solomon, S.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Overcoming drug resistance to Trk inhibition by rational combination of entrectinib and trametinib: From bench to bedside
    Meeting Abstract

    Ho, A.; Wei, G.; Maneval, E. C.; Esquibel, V.; Berger, M. F.; Haque, S.; Patel, R.; Walsh, C.; Hornby, Z.; Multani, P.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • SLFN11 is necessary for single agent sensitivity to talazoparib, a potent PARP inhibitor, but not for radiosensitization in small cell lung cancer (SCLC) cell lines and patient-derived xenografts (PDX)
    Meeting Abstract

    Lok, B. H.; Feng, Y.; Gardner, E. E.; Yu, G. K.; Ru, Y. K.; Riaz, N.; deStanchina, E.; Powell, S. N.; Shen, Y. J.; Poirier, J. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • Have adjuvant tyrosine kinase inhibitors lost their shine?
    Journal Article

    Sabari, J. K.; Chaft, J. E.
    Annals of Translational Medicine (2016)

    Fulltext@MSK | Save
  • CheckMate 017 and 057 studies of nivolumab vs docetaxel in patients with advanced NSCLC: 2-year-update and exploratory cytokine profile analyses
    Meeting Abstract

    Eberhardt, W. E. E.; Borghaei, H.; Brahmer, J. R.; Horn, L.; Ready, N.; Steins, M.; Felip, E.; Paz-Ares, L. G.; Arrieta, O.; Barlesi, F.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • Detection of ALK alternative transcription initiation and MET exon 14 skipping using nanoString digital nCounter technology in a clinical setting
    Meeting Abstract

    Borsu, L.; Mullaney, K.; Benayed, R.; Chi, P.; Busam, K.; Paik, P.; Drilon, A.; Ladanyi, M.
    Journal of Molecular Diagnostics (2016)

    Fulltext@MSK | Save
  • Genomic profile, smoking, and response to anti-PD-1 therapy in non-small cell lung carcinoma
    Journal Article

    Hellmann, M.; Rizvi, N.; Wolchok, J. D.; Chan, T. A.
    Molecular & Cellular Oncology (2016)

    Fulltext@MSK | Save
  • Chemotherapy remains an essential element of personalized care for persons with lung cancers
    Journal Article

    Hellmann, M. D.; Li, B. T.; Chaft, J. E.; Kris, M. G.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the lung: Clinico-pathologic features, treatment, and outcomes
    Journal Article

    Naidoo, J.; Santos-Zabala, M. L.; Iyriboz, T.; Woo, K. M.; Sima, C. S.; Fiore, J. J.; Kris, M. G.; Riely, G. J.; Lito, P.; Iqbal, A.; more...
    Clinical Lung Cancer (2016)

    Fulltext@MSK | Save